ASX-Dividend-Report-Banner

Transforming Healthcare with AI: YiduTech's Gong Rujing at Summer Davos

July 01, 2024 12:17 PM AEST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Transforming Healthcare with AI: YiduTech's Gong Rujing at Summer Davos
Image source: Kalkine Media

DALIAN, China, July 1, 2024 /PRNewswire/ -- "AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New Champions, also known as Summer Davos, in Dalian, Ms. Gong Rujing (Yingying), Chairwoman and Founder of Yidu Tech, was invited as a distinguished representative of the healthcare technology sector. She shared her unique insights into the future of AI in healthcare during the thematic dialogue on "Healthcare Analytics, Not Moving Fast Enough."

Gong Rujing speaking at the forum.
Gong Rujing speaking at the forum.

This year marks the 10th anniversary of Yidu Tech and Ms. Gong Rujing's decade-long dedication to the healthcare industry. "I will continue this mission for decades to come and strive to do even better," she stated. From the inception of her entrepreneurial journey 10 years ago, she has been driven by the mission to leverage the power of technology to deliver precise healthcare to every individual.

Ms. Gong described the past decade as a journey filled with miracles and achievements. During this period, Yidu Tech has progressively established close collaborations with key stakeholders in the healthcare industry, including government agencies, hospitals, pharmaceutical companies, insurance firms, experts, and clinicians. As of March 31, 2024, Yidu Tech's "AI Medical Brain" YiduCore has been authorized to process and analyze over 5 billion medical records, covering more than 2,500 hospitals. Leveraging YiduCore's accumulated understanding of AI technology and medical knowledge, Yidu Tech and its partners are jointly driving innovation and progress in the healthcare field.

In regional population health management, Yidu Tech has assisted in constructing urban "health brains," with several benchmark projects implemented in cities such as Beijing and Ningbo. In AI-powered clinical research, Yidu Tech has supported researchers and clinicians in producing over 240 high-level papers, accelerating the application of research outcomes. Additionally, Yidu Tech provides clinical trial services to globally renowned pharmaceutical companies, helping them optimize trial processes, reduce costs, and bring new drugs to market more swiftly, ultimately benefiting patients. In healthcare management, Yidu Tech's AI technology plays a crucial role by analyzing vast amounts of medical data to provide comprehensive decision support to healthcare administrators, helping them optimize resource allocation and improve service efficiency. The number of active users on Yidu Tech's health management platform, each completing at least one transaction, has reached nearly 27.6 million. "These achievements are all empowered by medical data analysis and AI technology."

"We are now entering a new era of AI technology." The development of large language model technologies has opened up new possibilities across various industries. Yidu Tech has independently developed a large model specific to the medical field and is advancing its application across the entire healthcare industry chain, including medicine, pharmaceuticals, insurance, and patients. The goal is to promote further progress and innovation through new AI technologies. However, Ms. Gong also emphasized that the healthcare industry is professional, complex, and sensitive, and the application of new technologies must address challenges such as data security, privacy protection, and ethics.

"Data security and privacy protection are fundamental to the development of AI technology and medical big data technology. We must ensure that all stakeholders are satisfied with compliance, security, accessibility, and privacy protection." She illustrated this point with a vivid example: "If a patient is in a coma and in critical condition, unable to express their wishes, should the doctor immediately access their medical records without the patient's consent? This requires deep consideration and balance."

"AI technology still has a long way to go." She called on policymakers, healthcare institutions, and technology companies to work together to realize the immense potential of healthcare data. Ms. Gong highlighted that building trust is key, and enhancing data operability is essential to fully unleash the power of data. "It's not just about better data quality; it's about a better future for health."

Joining Ms. Gong in the dialogue were Professor Chong Yap Seng, Dean of the Yong Loo Lin School of Medicine at the National University of Singapore; Dr. Brandon Suh, CEO of Lunit; and Dr. Angela Wang Nan, Senior Vice President and Chief Investment Officer of Neusoft Group, and Chairman and President of Neusoft Europe.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.